For the quarter ending 2025-09-30, SNTI has $52,685K in assets. $44,564K in debts. $12,243K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 12,243 | 21,576 | ||
| Accounts receivable-Nonrelated Party | 147 | 168 | ||
| Accounts receivable-Related Party | 1,597 | 3,524 | ||
| Prepaid expenses and other current assets-Related Party | 2,067 | 5,483 | ||
| Prepaid expenses and other current assets-Nonrelated Party | 2,104 | 1,770 | ||
| Total current assets | 18,158 | 32,521 | ||
| Restricted cash | 3,540 | 3,529 | ||
| Property and equipment, net | 18,691 | 19,593 | ||
| Operating lease right-of-use assets | 12,262 | 12,845 | ||
| Other non-current assets | 34 | 52 | ||
| Total assets | 52,685 | 68,540 | ||
| Accounts payable | 1,771 | 1,020 | ||
| Accrued expenses and other current liabilities | 5,103 | 3,628 | ||
| Operating lease liabilities, current | 5,153 | 4,979 | ||
| Genefab sublease deferred income - related party | 0 | 360 | ||
| Total current liabilities | 12,027 | 9,987 | ||
| Operating lease liabilities, non-current | 24,968 | 26,332 | ||
| Other non-current liabilities | 7,569 | 7,569 | ||
| Total liabilities | 44,564 | 43,888 | ||
| Common stock, 0.0001 par value 500,000,000 shares authorized as of both september30, 2025 and december31, 2024 26,290,838 and 4,829,035 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively | 3 | 3 | ||
| Additional paid-in capital | 352,223 | 350,628 | ||
| Accumulated deficit | -344,105 | -325,979 | ||
| Total stockholders equity | 8,121 | 24,652 | ||
| Total liabilities and stockholders equity | 52,685 | 68,540 | ||
Senti Biosciences, Inc. (SNTI)
Senti Biosciences, Inc. (SNTI)